A new an­ti-ag­ing biotech wants to add 10 years to your life. But who's fund­ing it?

4 years ago
Financing
Startups

Psych and neu­ro R&D notch a win as BioX­cel gets FDA ap­proval for schiz­o­phre­nia, bipo­lar dis­or­der-re­lat­ed ag­i­ta­tion

4 years ago
AI
FDA+

FDA's court-man­dat­ed re­lease of Pfiz­er Covid-19 vac­cine doc­u­ments con­tin­ues to turn over few sur­pris­es

4 years ago
FDA+
Coronavirus

5AM dash­es out of the gate, kick­ing off Q2 with $750M in two new funds

4 years ago
Financing

FDA halts the use of GSK's Covid-19 drug com­plete­ly as BA.2 sub­vari­ant blan­kets the coun­try

4 years ago
FDA+
Coronavirus

Build­ing on its reti­nal dis­ease ex­per­tise, Re­gen­eron signs eye-fo­cused gene ther­a­py pact with Ger­man biotech

4 years ago
Deals

No­var­tis' PI3K drug, al­ready ap­proved in breast can­cer, nabs a speedy OK to treat ul­tra-rare con­di­tion

4 years ago
Pharma
FDA+

As part of broad­er gene ther­a­py am­bi­tions, Take­da links up again with a small Chica­go biotech

4 years ago
Startups
Pharma

Af­ter Covid-19 suc­cess, pa­tients with the world’s ‘most stig­ma­tized’ in­fec­tion push for their own Op­er­a­tion ...

4 years ago
In Focus

'S­tuck in the past': Athi­ra hits back at bil­lion­aire backer and his bid to put oust­ed CEO Leen Kawas back in the ...

4 years ago
People

Scoop: One of Phil Krause’s post-FDA gigs, a biotech try­ing to de­vel­op a Shin­grix com­peti­tor, goes up for sale

4 years ago
People
Startups

Fresh off an $11.5B car­dio wa­ger, Mer­ck promis­es in­vestors a megablock­buster fu­ture in a re­turn to the glo­ry days

4 years ago
Pharma

The bill on Mer­ck­'s C-suite shake­up in­cludes about $30M for dual CEO pay pack­ages

4 years ago
People
Pharma

No­var­tis man­u­fac­tur­ing fa­cil­i­ty in North Car­oli­na gets FDA all-clear to pro­duce, ship gene ther­a­pies

4 years ago
Pharma
Manufacturing

Boehringer In­gel­heim boosts R&D com­mit­ment, promis­es up to 15 new prod­uct launch­es by 2025

4 years ago
R&D
Pharma

Sen­a­tors grill in­dus­try groups over FDA user fee agree­ments to fund the agency through 2027

4 years ago
FDA+

Sen­a­tors call on HHS to in­ves­ti­gate McK­in­sey's al­leged ties with FDA, opi­oid man­u­fac­tur­ers

4 years ago
Pharma
FDA+

What's go­ing on with Mer­ck­'s off­shore tax prac­tices as tax rate plunges to 11% and Sen­ate Fi­nance Chair Ron Wyden ...

4 years ago
Pharma

Mar­ket­ingRx roundup: Mer­ck re­ups HPV ads for young adults; Idor­sia study con­firms lit­tle sleep for weary

4 years ago
Pharma
Marketing

No­vo Nordisk trades Ry­bel­sus' an­i­mat­ed Covid-launch ads for ‘more re­lat­able’ live ac­tion cam­paign

4 years ago
Pharma
Marketing

Glax­o­SmithK­line keeps truck­ing along­side AI with new, mul­ti-year pathol­o­gy part­ner­ship with Boston out­fit

4 years ago
Deals
AI

PhI­Ib im­plo­sion punts Imara back to pre­clin­i­cal mode as biotech ax­es pro­grams in sick­le cell dis­ease, ...

4 years ago
R&D

David Saba­ti­ni re­signs MIT pro­fes­sor­ship af­ter sex­u­al ha­rass­ment probe led to ouster from White­head In­sti­tute

4 years ago
People

Who are the LGBTQ+ lead­ers forg­ing paths in bio­phar­ma in 2022? Nom­i­nate them for an End­points spe­cial re­port

4 years ago
People
R&D
First page Previous page 554555556557558559560 Next page Last page
A service from the Financial Times